BRIEF: Gavi seeks to claw back $224 million prepayment from Clover
Biotechnology firm Clover Biopharmaceuticals Ltd. (2197.HK) said on Monday that it received an arbitration claim on June 6 seeking return of a $224 million prepayment from global vaccine alliance Gavi.…
Recent Articles
RELATED ARTICLES
-
Dispute over Covid vaccines casts doubt on Clover Bio recovery
2197.HK -
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
ZYBT.US
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK
-
BRIEF: Jihong Group seeks up to $93 million in Hong Kong IPO
2603.HK 002803.SHE
- Coconut water maker If seeks investor warmth in Hong Kong
-
BRIEF: Synagistics to acquire Chinese AI firm for $30 million
2562.HK
